Dipentum Oral Capsule 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Dipentum: Oral capsule (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_11832.JPG
Dipentum 250mg Cap
Meda Pharmaceuticals formerly Alaven Pharmaceuticals LLC
Pill Identification: DIPENTUM 250 mg 

What is this Medicine?

OLSALAZINE (ole SAL a zeen) is used to treat ulcerative colitis. This medicine is also used to help maintain remission of the disease.

CVS Pharmacy Patient Statistics for Dipentum: Oral capsule(250mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Dipentum 250mg Capsule

NDC: 682200160
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Ulcerative Colitis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Dipentum 250mg Capsule
Drug Image file DrugItem_11832.JPG
Meda Pharmaceuticals formerly Alaven Pharmaceuticals LLC
Pill Identification: DIPENTUM 250 mg 
Shape: capsule
Color: beige

Reported Side Effects for Dipentum 250mg Capsule

Balance Problems Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.3%*
Severity: MILD
Onset: RAPID
Decreased Appetite Incidence:
1.3%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
1.5%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Tiredness Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Tired Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
10.1%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
11.1-17.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Dipentum

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5